To assess whether PMC42-LA derived tumors also display a similar proportion of epithelial mesenchymal heterogeneity as found in vitro, a xenograft tumor was immunostained for both EpCAM (red) and vimentin (green) (Figure 4B). The gene discussed is EPCAM; the disease is neoplasm.